Home›Treatments›Asthma›Pulmicort

Pulmicort Turbohaler (Budesonide Inhaler)

Pulmicort Turbohaler is a 'preventer' inhaler prescribed for the daily management of asthma. Its active ingredient, budesonide, is a corticosteroid that works by reducing inflammation and swelling in the airways, making them less sensitive to triggers. Used regularly, it helps prevent asthma symptoms like wheezing and breathlessness from occurring. It is crucial to use this inhaler every day, even when you feel well, alongside your 'reliever' inhaler for sudden symptoms. This treatment is part of a long-term strategy to control your asthma and improve your quality of life.
Complete a short online consultation so our prescriber can confirm the treatment suits you.
The decision to supply the specific treatment and quantity requested will be based on whether our medical team are satisfied that it will be safe, appropriate, and effective.
Or 3 interest-free payments of £11.53 via Klarna
Tracked 24 Delivery3 interest-free payments via KlarnaDiscreet packaging

Pulmicort Treatment

Product NamePulmicort
ManufacturerAstraZeneca
Active IngredientBudesonide
AdministrationOral Inhalation
PresentationDry Powder Inhaler (Turbohaler device)
Available Strengths100 mcg / 1 Inhaler, 200 mcg / 1 Inhaler, 300 mcg / 1 Inhaler
Product TypePOM — Prescription Only
Starting Price£34.59
Suitable for pregnancy?Consult Doctor
Use with alcoholCompatible
Link to Patient Information LeafletPulmicort PIL ↗
Authored byNabeel

Medical Content Manager

Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Talal is a GMC registered doctor and medical reviewer at Chemist Doctor. He ensures clinical accuracy and reliability across health content.

Approved byUsman

Medical Director

Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 2 Jul 2026

Next Review: 1 Jan 2027

Published on: 19 Nov 2025

Last Updated: 3 Jul 2026